MicroRNA-409-3p regulates macrophage migration in polymyositis through targeting CXCR4

Qin Ye1, Zhaoying Chen2

  • 1Department of Pulmonary Medicine, Ningbo HwaMei Hospital, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, P. R. China.

Autoimmunity
|June 18, 2021
PubMed
Abstract

Insights

MicroRNA-409-3p (miR-409-3p) is reduced in polymyositis (PM) and inhibits macrophage migration by targeting CXCR4. Restoring miR-409-3p levels may offer a therapeutic strategy for PM.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Macrophage migration is crucial in polymyositis (PM) pathogenesis.
  • Understanding the regulatory mechanisms of macrophage migration in PM is vital.

Purpose of the Study:

  • To investigate the role and mechanism of microRNA-409-3p (miR-409-3p) in regulating macrophage migration in PM.

Main Methods:

  • Bioinformatic analysis (GSE143845 database) and qRT-PCR to assess miRNA expression.
  • Transwell assays, Western blot, and luciferase assays to evaluate macrophage migration and molecular interactions.
  • Establishment of an experimental autoimmune myositis (EAM) mouse model for in vivo validation.

Main Results:

  • miR-409-3p was significantly downregulated in PM patients and database samples.
  • miR-409-3p mimic reduced macrophage migration and CXCR4 expression, while inhibitor increased them.
  • CXCR4 was identified as a direct target of miR-409-3p, and its pro-migratory effect was reversed by miR-409-3p.
  • In vivo studies showed miR-409-3p agomir reduced inflammation and macrophage infiltration in EAM mice.

Conclusions:

  • miR-409-3p acts as a negative regulator of macrophage migration in PM by targeting CXCR4.
  • Restoring miR-409-3p levels presents a potential therapeutic avenue for polymyositis.